With the FDA approval of brensocatib, the first approved treatment specifically for non-cystic fibrosis bronchiectasis, what does this breakthrough mean for patients and clinicians? In this episode of the ATS Breathe Easy podcast, host Ugo Ezema, MD, Tulane, speaks with ATS Treasurer Gregory Tino, MD, ATSF, University of Pennsylvania, about the science behind brensocatib, findings from the ASPEN clinical trial, and promising new therapies on the horizon.

Artificial intelligence is transforming respiratory care, from detecting lung nodules to assessing cancer risk, all to help physicians make faster, more informed decisions. In this episode of the ATS Breathe Easy podcast, host Patti Tripathi speaks with James Finigan, MD, National Jewish Health, about how AI is being integrated into respiratory cancer care. He explains how AI can help with lung cancer diagnosis, the difference between assistive and augmentative AI, and what physicians need to know as these technologies become part of their clinical practice.

Career paths are rarely straight roads, instead taking unexpected twists and turns. Past ATS President M. Patricia Rivera, MD, ATSF, tells host Ugo Ezema, Tulane, how her career shifted and changed as she grew as both a professional and a person. She also provides advice for those early and mid-career professionals who are thinking about their next moves and how to navigate challenges that may come up along the way.